Back
DiaMedica Therapeutics Inc. DMAC · Insights
DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advan... Price9.65
Market Cap504.74 M
Float25.3 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro